
Yahoo · 16 de oct de 2026
Medtronic exchanged all of its remaining shares of the diabetes technology spinoff.
Medtronic Public Limited Company
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
Últimos 226 días · 12/11/25 — 16/10/26
+8.55%
Precio
$ 38.360
Var. %
-1,03%
Volumen operado
124
Precio MDT
US$ 94,95
Teórico (precio / ratio)
MDT ÷ 4
US$ 23,74
Sí, existe el CEDEAR de MDT (Medtronic Public Limited Company) en la Bolsa de Comercio de Buenos Aires (BYMA). Su ticker local es MDT.
El ticker del CEDEAR de Medtronic Public Limited Company en Argentina es MDT. La acción subyacente cotiza en NYSE con el símbolo MDT.
El CEDEAR MDT tiene un ratio de 4:1. Eso significa que 4 CEDEARs equivalen a 1 acción de MDT.
El CEDEAR MDT cotiza hoy a $ 38.360 en pesos argentinos, con una variación diaria de -1,03%.

Yahoo · 16 de oct de 2026
Medtronic exchanged all of its remaining shares of the diabetes technology spinoff.

Yahoo · 16 de oct de 2026
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the completion of the compan…

Yahoo · 16 de oct de 2026
MDT expands in cardiac ablation, robotics, hypertension and digital surgery, but tariff, inflation and currency risks are likely to pressure margins.
Precio de cierre en pesos argentinos. Fuente: data912.
Cotización
US$ 25,09
vs teórico
+5,7%
Cotización MEP implícita
$ 1.528,9
Cotización
—
vs teórico
—
Cotización Cable implícita
—
La acción subyacente MDT (Medtronic Public Limited Company) cotiza a US$ 94,95 en su mercado de origen (NYSE).
El precio teórico del CEDEAR MDT se calcula dividiendo el precio de MDT por el ratio (4). Hoy resulta en US$ 23,74.
En BYMA podés operar MDT en pesos, MDTD en dólar MEP y MDTC en dólar cable. Cada modalidad refleja un tipo de cambio distinto.
En esta página encontrás un gráfico con el precio histórico del CEDEAR MDT en pesos argentinos, con datos de data912.

Yahoo · 15 de oct de 2026
Investors considering Medtronic (MDT) stock face an immediate concern: the shares returned 1.9% over the past year, trailing the 17.3% gain for the S&P 500. Yet…

Yahoo · 15 de oct de 2026
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Stealth AXiS™ surgical system and the Corsano™* multi-parameter we…

Yahoo · 15 de oct de 2026
Investors in Boston Scientific (BSX) hold stakes in a medical device maker that grew revenue 13.5% over the twelve months to June 2026. Yet the shares have lost…

Yahoo · 15 de oct de 2026
A dividend that keeps growing beats a fat yield that gets cut, but only if the company can actually afford to keep raising it. These five blue chips clear that…
Benzinga · 15 de oct de 2026
MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the completion of the compan…
Noticias vía Finnhub